Cambridge Innovation Capital is an established VC firm embedded in the UK technology ecosystem with privileged access to the University of Cambridge. The firm manages over £600m of capital and invests across deep tech and life sciences.
The Series C round was led by Planet First Partners to support scaling and technological roadmaps.
"Quantum error correction is the critical enabler for the industry’s next huge wave of progress, from today’s small error-prone machines to large and reliable quantum computers that will start a new age of human progress as significant as the digital revolution."
The largest European semiconductor venture funding round to date will support the construction of new fabrication lines in the UK.
"This successful Series D round is a clear testament to the massive opportunity for our innovative technology to enable item-level intelligence in virtually any object on the planet. Our global customers value our ultra-thin and flexible form factor, our breakthrough low cost of customisation and rapid production cycles, as well as the lower environmental footprint compared to silicon. Scaling our manufacturing capacity on the UK’s first ever 300mm wafer production lines at our site in Durham will enable us to deliver hundreds of billions of chips to customers worldwide over the coming decade."
Mazda joined existing investors Amadeus Capital Partners, Atlantic Bridge Ventures, and Cambridge Innovation Capital in backing the Cambridge-based firm.
"Secondmind and Mazda have been aligned from day one around a common goal of enabling continuous optimization of vehicle design and performance and helping the automotive industry deliver in the era of the software-defined vehicle. This expanded strategic partnership agreement strengthens our long-standing relationship of deep collaboration, and we are proud to support Mazda in opening new avenues for AI innovation in automotive engineering by way of Mazda’s advanced AI research and education strategy. We’re excited to welcome Mazda as an investor in this funding round alongside Amadeus Capital Partners, Atlantic Bridge, and Cambridge Innovation Capital, and we look forward to leveraging this infusion of capital to accelerate the development and commercial deployment of more high-value system design optimization and calibration applications for Mazda and the automotive industry at large."
The financing round was led by Sofinnova Partners, F-Prime Capital, Digitalis Ventures and Cambridge Innovation Capital.
"We’re delighted to have raised this Series A with such high-quality investors whose amazing networks and shared vision will help us deliver highly differentiated TCR cancer therapies. TCR therapeutics are very much at the dawn of their potential. We intend to replicate the success of therapeutic antibodies but build on this in a new dimension, by using the targeting domains of TCR receptors to take advantage of their much greater specificity for cancer cells compared to normal cells. The same logic can be used to target immunosuppressive biologics to tissues impacted by autoimmune disorders."
The upsized funding round was led by existing backers including Ally Bridge Group and Lightrock.
"Versius is very well suited to our needs as a world-leading thoracic surgery department. We have successfully helped patients get the benefit of robotic assisted surgery and we look forward to developing our robotics programme working with CMR and other centres around the world as the adoption of Versius continues."
